800.00p+50.00 (+6.67 %)15 Jan 2021, 18:10
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Renalytix Ai PLC Market & Company News

13.01.2021 16:35Price Monitoring ExtensionRNS
13.01.2021 07:00Finalization of MCIT rule for coverage pathwayRNS
05.01.2021 16:41Second Price Monitoring ExtnRNS
05.01.2021 16:36Price Monitoring ExtensionRNS
05.01.2021 07:00Partnership Between RenalytixAI and DaVitaRNS
07.12.2020 15:45Result of AGMRNS
02.12.2020 13:08Partnership with National Kidney FoundationRNS
26.11.2020 07:01Holding(s) in CompanyRNS
26.11.2020 07:00Sale of shares in Renalytix AI plcRNS
25.11.2020 16:41Second Price Monitoring ExtnRNS
25.11.2020 16:35Price Monitoring ExtensionRNS
25.11.2020 07:00Financial Results for First Quarter of FY 2021RNS
06.11.2020 07:00Change of AdviserRNS
02.11.2020 15:30Posting of Annual Report & Accounts &Notice of AGMRNS
28.10.2020 14:15Re-issued: EKF marketing & distribution agreementRNS
27.10.2020 07:00Full Year ReportRNS
20.10.2020 11:00Schedule One - Verici Dx PLCRNS
16.10.2020 06:00Notice of ResultsRNS
13.10.2020 14:32Verici Dx - Intention to admit to trading on AIMRNS
22.09.2020 06:00California Commercial Lab Certification RecievedRNS
18.09.2020 06:00KidneyIntelX clinical testing launchRNS
02.09.2020 06:00Grant of Purchase Rights and Verici updateRNS
26.08.2020 06:00Submission seeking FDA Clearance of KidneyIntelXRNS
21.08.2020 07:00RenalytixAI to Collaborate with AstraZenecaRNS
03.08.2020 06:00KidneyIntelX in Multi-Center StudyRNS
31.07.2020 15:31Total Voting RightsRNS
27.07.2020 06:00Over allotment option exerciseRNS
21.07.2020 16:30Closing of Global Offering and resulting TVRRNS
17.07.2020 06:00Pricing of Global OfferingRNS
13.07.2020 11:01Launch of Global Offering and application to listRNS
13.07.2020 10:45Result of General MeetingRNS
08.07.2020 06:01Approval of distribution of shares in Verici DxRNS
08.07.2020 06:00Partnership with America’s Choice Provider NetworkRNS
07.07.2020 06:00Holding(s) in CompanyRNS
30.06.2020 06:00University of Michigan Partnership & Data SharingRNS
25.06.2020 06:01Proposed Board changes; Circular & Notice of GMRNS
25.06.2020 06:00Public filing re. Nasdaq dual-listing and offeringRNS
12.06.2020 06:00KidneyIntelX™ receives New York State approvalRNS
10.06.2020 07:00Confirmation of reduction of capitalRNS
10.06.2020 06:00Positive results of clinical validation studyRNS
20.05.2020 10:06Second Price Monitoring ExtnRNS
20.05.2020 10:00Price Monitoring ExtensionRNS
20.05.2020 06:00JV for COVID-19 antibody test scaled productionRNS
18.05.2020 06:00Proposed dual-listing on NasdaqRNS
15.05.2020 12:02Result of General MeetingRNS
05.05.2020 09:55Removal of US Securities Law RestrictionsRNS
28.04.2020 06:00Update re. potential demerger of FractalDxRNS
20.04.2020 06:00KidneyIntelX used in Mount Sinai COVID-19 studyRNS
15.04.2020 06:00Provider network agreement for KidneyIntelX™RNS
01.04.2020 06:00Medicare provider numberRNS
27.03.2020 10:32Holding(s) in CompanyRNS
03.03.2020 07:00Half-year ReportRNS
26.02.2020 07:00Notice of ResultsRNS
08.01.2020 07:00New commercial testing facility opens in UtahRNS
03.12.2019 07:00Medicare sets US national price for KidneyIntelXRNS
21.11.2019 07:00Grant of OptionsRNS
17.10.2019 06:00Partnership with CDPHP on KidneyIntelXRNS
14.10.2019 06:00Board appointmentRNS
01.10.2019 06:00US CPT® reimbursement code effectiveRNS
30.09.2019 15:37Result of AGMRNS
30.09.2019 07:00Update on non-executive director appointmentRNS
30.09.2019 06:00Preliminary Medicare Pricing DeterminationRNS
06.09.2019 15:00Posting of Annual Report & Accounts &Notice of AGMRNS
03.09.2019 06:00Final ResultsRNS
20.08.2019 06:00Notice of ResultsRNS
06.08.2019 06:00Expansion of Chronic Kidney Disease Advisory BoardRNS
31.07.2019 15:30Total Voting RightsRNS
23.07.2019 17:23Result of Placing & Total Voting RightsRNS
23.07.2019 06:01Proposed Placing to raise £12.0m (c.US$15.0m)RNS
09.07.2019 06:00Positive Interim Results for Validation StudyRNS
01.07.2019 06:00US CPT® Code Granted for KidneyIntelX(TM)RNS
02.05.2019 13:05Second Price Monitoring ExtnRNS
02.05.2019 13:00Price Monitoring ExtensionRNS
02.05.2019 06:00FDA grants Breakthrough Device designationRNS
26.04.2019 17:20Acquisition of further interest in Renalytix AIRNS
26.04.2019 16:42Director/PDMR ShareholdingRNS
02.04.2019 11:55Holding(s) in CompanyRNS
01.04.2019 06:00Publication of confirmation study resultsRNS
25.03.2019 07:00Half-year ReportRNS
14.02.2019 07:00Appointment of Nomad and Joint BrokerRNS
13.02.2019 07:00Joint venture partnership agreement with AKESOgenRNS
23.01.2019 07:00Initiates Clinical Validation StudyRNS
21.01.2019 07:00Clarification re. lock-up restrictionsRNS
02.01.2019 07:00Exercise of Option for Exclusive LicenseRNS
20.12.2018 17:20Director/PDMR ShareholdingRNS
20.12.2018 07:01Planned appointment of joint broker & of NOMADRNS
19.12.2018 18:28Director DealingRNS
17.12.2018 13:30Holding(s) in CompanyRNS
09.11.2018 10:30Holding(s) in CompanyRNS
08.11.2018 16:50Holding(s) in CompanyRNS
08.11.2018 07:00Director/PDMR ShareholdingRNS
06.11.2018 07:00RENX Admission to AIM and First Day of DealingsRNS
Showing 1 to 100 of 1,000